Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Colocalisation of CD9 and mortalin in CD9-induced mitotic catastrophe in human prostate cancer cells.

Zvereff V, Wang JC, Shun K, Lacoste J, Chevrette M.

Br J Cancer. 2007 Oct 8;97(7):941-8. Epub 2007 Sep 11.

2.

Over-expression of CD9 does not affect in vivo tumorigenic or metastatic properties of human prostate cancer cells.

Zvieriev V, Wang JC, Chevrette M.

Biochem Biophys Res Commun. 2005 Nov 18;337(2):498-504. Epub 2005 Sep 21.

PMID:
16198313
3.

Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications.

Wang JC, Bégin LR, Bérubé NG, Chevalier S, Aprikian AG, Gourdeau H, Chevrette M.

Clin Cancer Res. 2007 Apr 15;13(8):2354-61. Epub 2007 Apr 3.

4.

The nuclear pool of tetraspanin CD9 contributes to mitotic processes in human breast carcinoma.

Rappa G, Green TM, Lorico A.

Mol Cancer Res. 2014 Dec;12(12):1840-50. doi: 10.1158/1541-7786.MCR-14-0242. Epub 2014 Aug 7.

5.

Native type IV collagen induces cell migration through a CD9 and DDR1-dependent pathway in MDA-MB-231 breast cancer cells.

Castro-Sanchez L, Soto-Guzman A, Navarro-Tito N, Martinez-Orozco R, Salazar EP.

Eur J Cell Biol. 2010 Nov;89(11):843-52. doi: 10.1016/j.ejcb.2010.07.004. Epub 2010 Aug 14.

PMID:
20709424
6.

CD9-mediated activation of the p46 Shc isoform leads to apoptosis in cancer cells.

Murayama Y, Miyagawa J, Oritani K, Yoshida H, Yamamoto K, Kishida O, Miyazaki T, Tsutsui S, Kiyohara T, Miyazaki Y, Higashiyama S, Matsuzawa Y, Shinomura Y.

J Cell Sci. 2004 Jul 1;117(Pt 15):3379-88.

7.

Direct binding of the ligand PSG17 to CD9 requires a CD9 site essential for sperm-egg fusion.

Ellerman DA, Ha C, Primakoff P, Myles DG, Dveksler GS.

Mol Biol Cell. 2003 Dec;14(12):5098-103. Epub 2003 Oct 3.

8.

The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells.

Murayama Y, Shinomura Y, Oritani K, Miyagawa J, Yoshida H, Nishida M, Katsube F, Shiraga M, Miyazaki T, Nakamoto T, Tsutsui S, Tamura S, Higashiyama S, Shimomura I, Hayashi N.

J Cell Physiol. 2008 Jul;216(1):135-43. doi: 10.1002/jcp.21384.

PMID:
18247373
9.

EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.

Zhang XA, Lane WS, Charrin S, Rubinstein E, Liu L.

Cancer Res. 2003 May 15;63(10):2665-74.

10.

RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis.

Ishii M, Iwai K, Koike M, Ohshima S, Kudo-Tanaka E, Ishii T, Mima T, Katada Y, Miyatake K, Uchiyama Y, Saeki Y.

J Bone Miner Res. 2006 Jun;21(6):965-76.

11.

Tetraspanin protein CD9 interacts with metalloprotease CD10 and enhances its release via exosomes.

Mazurov D, Barbashova L, Filatov A.

FEBS J. 2013 Mar;280(5):1200-13. doi: 10.1111/febs.12110. Epub 2013 Feb 6.

12.

HSP27 and HSP70 interact with CD10 in C4-2 prostate cancer cells.

Dall'Era MA, Oudes A, Martin DB, Liu AY.

Prostate. 2007 May 15;67(7):714-21.

PMID:
17342744
13.

Tetraspanin CD9 induces MMP-2 expression by activating p38 MAPK, JNK and c-Jun pathways in human melanoma cells.

Hong IK, Kim YM, Jeoung DI, Kim KC, Lee H.

Exp Mol Med. 2005 Jun 30;37(3):230-9.

14.

Tetraspanin CD9 is involved in the migration of retinal microvascular endothelial cells.

Deissler H, Kuhn EM, Lang GE, Deissler H.

Int J Mol Med. 2007 Nov;20(5):643-52.

PMID:
17912457
15.

Functional and biochemical studies of CD9 in fibrosarcoma cell line.

Chen S, Sun Y, Jin Z, Jing X.

Mol Cell Biochem. 2011 Apr;350(1-2):89-99. doi: 10.1007/s11010-010-0685-1. Epub 2010 Dec 14.

PMID:
21161334
16.

The tetraspanin protein, CD9, is expressed by progenitor cells committed to oligodendrogenesis and is linked to beta1 integrin, CD81, and Tspan-2.

Terada N, Baracskay K, Kinter M, Melrose S, Brophy PJ, Boucheix C, Bjartmar C, Kidd G, Trapp BD.

Glia. 2002 Dec;40(3):350-9.

PMID:
12420314
18.

Knockout of the tetraspanin Cd9 in the TRAMP model of de novo prostate cancer increases spontaneous metastases in an organ-specific manner.

Copeland BT, Bowman MJ, Boucheix C, Ashman LK.

Int J Cancer. 2013 Oct 15;133(8):1803-12. doi: 10.1002/ijc.28204. Epub 2013 May 15.

19.

Single-molecule analysis of CD9 dynamics and partitioning reveals multiple modes of interaction in the tetraspanin web.

Espenel C, Margeat E, Dosset P, Arduise C, Le Grimellec C, Royer CA, Boucheix C, Rubinstein E, Milhiet PE.

J Cell Biol. 2008 Aug 25;182(4):765-76. doi: 10.1083/jcb.200803010. Epub 2008 Aug 18.

20.

EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells.

Charrin S, Le Naour F, Labas V, Billard M, Le Caer JP, Emile JF, Petit MA, Boucheix C, Rubinstein E.

Biochem J. 2003 Jul 15;373(Pt 2):409-21.

Items per page

Supplemental Content

Write to the Help Desk